Edwards Lifesciences (EW) Net Cash Flow (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Net Cash Flow of -$500.2 million for Q1 2026, down 564.44% year-over-year from $107.7 million in Q1 2025, and down 307.38% quarter-over-quarter from $241.2 million in Q4 2025.
Edwards Lifesciences (EW) Net Cash Flow (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Net Cash Flow history runs 18 years deep, the most recent figure standing at -$500.2 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 564.44% year-over-year to -$500.2 million; the TTM figure through Mar 2026 stood at -$682.4 million (down 135.75% YoY), while the FY2025 annual figure was -$74.5 million, down 103.98% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$500.2 million, down from $241.2 million in the prior quarter.
- The five-year high for Net Cash Flow was $2.1 billion in Q3 2024, with the low at -$675.6 million in Q4 2024.
- The 5-year median for Net Cash Flow is $108.0 million (2023), against an average of $90.7 million.
- The sharpest annual moves came in 2023 and 2026: Net Cash Flow surged 827.79% in 2023, then plunged 564.44% in 2026.
- Edwards Lifesciences' Net Cash Flow stood at -$460.9 million in 2022, then soared by 43.05% to -$262.5 million in 2023, then slumped by 157.37% to -$675.6 million in 2024, then jumped by 135.7% to $241.2 million in 2025, then tumbled by 307.38% to -$500.2 million in 2026.
- Business Quant data shows EW's Net Cash Flow at -$500.2 million in Q1 2026, $241.2 million in Q4 2025, and -$594.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.31 Bn | 193.71 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 129.55 Bn | 126.08 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 119.91 Bn | 110.69 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 74.06 Bn | 73.52 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.20 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 458.40 Mn |
| Jun 30, 2026 | 458.40 Mn |
| Mar 31, 2026 | -500.20 Mn |
| Mar 31, 2026 | -500.20 Mn |
| Dec 31, 2025 | 241.20 Mn |
| Dec 31, 2025 | 241.20 Mn |
| Sep 30, 2025 | -594.20 Mn |
| Sep 30, 2025 | -594.20 Mn |
| Jun 30, 2025 | 170.80 Mn |
| Jun 30, 2025 | 170.80 Mn |
| Mar 31, 2025 | 107.70 Mn |
| Mar 31, 2025 | 107.70 Mn |
| Dec 31, 2024 | -675.60 Mn |
| Dec 31, 2024 | -675.60 Mn |
| Sep 30, 2024 | 2.08 Bn |
| Sep 30, 2024 | 2.08 Bn |
| Jun 30, 2024 | 399.70 Mn |
| Jun 30, 2024 | 399.70 Mn |
| Mar 31, 2024 | 71.30 Mn |
| Mar 31, 2024 | 71.30 Mn |